Skip to content

ANSELMO PHARMA

Active Risk: not assessed Private limited companyfounded 2023active for 3 yearsDraakplaats 4, 2018 AntwerpKBO/BCE: BE 0798.184.888

Lifetime

3 annual accounts with figures on one time axis
peak of €110,493 in 2025
€110,493▲ 1.1%
peak of €62,258 in 2025
€62,258▲ 3.6%
peak of €183,073 in 2025
€183,073▲ 50.5%
€777,209▼ 2.9%
Board1 name since 2023
1 director
Documentsfilings and deeds
10-08-202610 days late
2025abbreviated format
Dividend €833Equity from €121,647 to €183,073Cash from €59,803 to €95,826

Key points

from the 2025 annual accounts

Equity

€183,073 ▲ 50.5%
€122,0002024€183,0002025

Equity rose in 2025 from €121,647 to €183,073.

Debts

€777,209 81% of the balance sheet
Financial debts 85%Taxes and wages 7%Other 8%

Of this, €104,724 falls due within a year.

Filings

3 annual accounts 2 late
AprilJune31 JulyOctober202320242025

The 2023 accounts came in latest, 26 days after the end of the period.

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.

Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 09-02-2023

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0798184888
First establishment Draakplaats 4, Antwerp
Incorporation Founding capital of €25,000, 100 shares · Founded by · appointed as director · published on 09-02-2023 · Gazette deed
All 9 events

Comparable companies

same main activity, similar in size and age
Company
ANSELMO PHARMA Antwerp €1.0m €110,493 19.1% -
GeJo Time Turnhout €0.9m €108,109 10.4% -
nathami Aartselaar €0.9m €114,621 -1.6% -
FAROSA BEHEER Schoten €0.8m €118,292 40.3% -
Meo Holding Wommelgem €1.1m €98,138 3.3% -
Govers Lille €1.0m €92,750 17.0% -
VH Pharma Beveren-Kruibeke-Zwijndrecht €0.9m €99,456 26.9% 0

These companies have the same main activity as ANSELMO PHARMA: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €839,000 and €1.1m, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 07-02-2023Normal situation
Activity
Activities of holding companiesNACE 64210
Establishment unit
2.341.737.9702018 Antwerp, since 01-04-2023
Financial year end
31 December
Peppol
Reachable since 25-11-2025
Company details

Annual accounts 2025

€960,281▲ 4.1%
Filing
Filed on 10-08-2026
Financials

Insights on ANSELMO PHARMA

ANSELMO PHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €72,091 in 2023 to €110,493 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ANSELMO PHARMA

What is the company number of ANSELMO PHARMA?
The company number of ANSELMO PHARMA is 0798.184.888. The VAT number is the same number with BE in front: BE 0798.184.888.
Where is ANSELMO PHARMA based?
The registered office is at Draakplaats 4, 2018 Antwerp.Company details
What does ANSELMO PHARMA do?
According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of ANSELMO PHARMA?
ANSELMO PHARMA is a private limited company (BV).
When was ANSELMO PHARMA founded?
ANSELMO PHARMA was founded on 07-02-2023.
Is ANSELMO PHARMA still active?
Yes, ANSELMO PHARMA is an active enterprise in the KBO register.
What is the turnover of ANSELMO PHARMA?
The turnover in financial year 2025 is about €170,000. This figure is estimated from the gross margin of €110,493 and 34 comparable companies (NACE 64210). It probably lies between €140,000 and €210,000.Financials
Is ANSELMO PHARMA profitable?
In financial year 2025, ANSELMO PHARMA made a profit of €62,258.
Where can I find the annual accounts of ANSELMO PHARMA?
ANSELMO PHARMA filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ANSELMO PHARMA due?
ANSELMO PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.